On the evening of November 11, 2018, the State Administration of Market Supervision and Administration announced the "Vaccine Management Law (Draft for Comment)" (hereinafter referred to as the "Draft for Comment") on the official website. It consists of 11 chapters, covering the development and marketing authorization of vaccines, Production and batch issuance, post-marketing research and management, vaccine circulation, vaccination, abnormal reaction monitoring and compensation, safeguards, supervision and management, legal responsibility, etc., make specific provisions for the special requirements of vaccine supervision.
Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
Copyright: Beijing Minhai Biological Technology Co., Ltd. 京ICP备10007676号-1 Powered by www.300.cn Beijing Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173
Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Medical support: 010-57864983